A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is ₺4.032,79, with a 24-hour trading volume of ₺17,43B. The asset's market cap is ₺12,5T, after moving 1.37% in the last day.
Tokenized AstraZeneca PLC is trading at ₺4.046,46, with a tokenized market cap of ₺30,34M and a 24-hour trading volume of ₺28,64M. The tokenized asset has moved 0.36% in the past 24 hours.